 | • レポートコード：MRC2Q12-16833 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、旅行者下痢症予防治療の世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に旅行者下痢症予防治療のグローバル市場のxxx％を占める「抗菌薬」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院 薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 旅行者下痢症予防治療の中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの旅行者下痢症予防治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 旅行者下痢症予防治療のグローバル主要プレイヤーには、Bayer AG、Johnson & Johnson、Merck & Co., Inc.、Novartis AG、Pfizer Inc.、Sanofi、GlaxoSmithKline plc、AstraZeneca、Bristol-Myers Squibb Company、Allergen Plc. Etc.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 旅行者下痢症予防治療市場は、種類と用途によって区分されます。世界の旅行者下痢症予防治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 抗菌薬、抗生物質、止瀉薬、電解質 【用途別セグメント】 病院 薬局、小売薬局、ドラッグストア、一次医療センター 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 旅行者下痢症予防治療製品概要 - 種類別市場（抗菌薬、抗生物質、止瀉薬、電解質） - 用途別市場（病院 薬局、小売薬局、ドラッグストア、一次医療センター） - 調査の目的 ・エグゼクティブサマリー - 世界の旅行者下痢症予防治療販売量予測2017-2028 - 世界の旅行者下痢症予防治療売上予測2017-2028 - 旅行者下痢症予防治療の地域別販売量 - 旅行者下痢症予防治療の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別旅行者下痢症予防治療販売量 - 主要メーカー別旅行者下痢症予防治療売上 - 主要メーカー別旅行者下痢症予防治療価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（抗菌薬、抗生物質、止瀉薬、電解質） - 旅行者下痢症予防治療の種類別販売量 - 旅行者下痢症予防治療の種類別売上 - 旅行者下痢症予防治療の種類別価格 ・用途別市場規模（病院 薬局、小売薬局、ドラッグストア、一次医療センター） - 旅行者下痢症予防治療の用途別販売量 - 旅行者下痢症予防治療の用途別売上 - 旅行者下痢症予防治療の用途別価格 ・北米市場 - 北米の旅行者下痢症予防治療市場規模（種類別、用途別） - 主要国別の旅行者下痢症予防治療市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの旅行者下痢症予防治療市場規模（種類別、用途別） - 主要国別の旅行者下痢症予防治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の旅行者下痢症予防治療市場規模（種類別、用途別） - 主要国別の旅行者下痢症予防治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の旅行者下痢症予防治療市場規模（種類別、用途別） - 主要国別の旅行者下痢症予防治療市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの旅行者下痢症予防治療市場規模（種類別、用途別） - 主要国別の旅行者下痢症予防治療市場規模（トルコ、サウジアラビア） ・企業情報 Bayer AG、Johnson & Johnson、Merck & Co., Inc.、Novartis AG、Pfizer Inc.、Sanofi、GlaxoSmithKline plc、AstraZeneca、Bristol-Myers Squibb Company、Allergen Plc. Etc. ・産業チェーン及び販売チャネル分析 - 旅行者下痢症予防治療の産業チェーン分析 - 旅行者下痢症予防治療の原材料 - 旅行者下痢症予防治療の生産プロセス - 旅行者下痢症予防治療の販売及びマーケティング - 旅行者下痢症予防治療の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 旅行者下痢症予防治療の産業動向 - 旅行者下痢症予防治療のマーケットドライバー - 旅行者下痢症予防治療の課題 - 旅行者下痢症予防治療の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Prophylactic Traveler’s Diarrhea Treatment estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Prophylactic Traveler’s Diarrhea Treatment is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Prophylactic Traveler’s Diarrhea Treatment is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Prophylactic Traveler’s Diarrhea Treatment is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Prophylactic Traveler’s Diarrhea Treatment include Bayer AG, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi, GlaxoSmithKline plc, AstraZeneca and Bristol-Myers Squibb Company, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Prophylactic Traveler’s Diarrhea Treatment companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Prophylactic Traveler’s Diarrhea Treatment market. Further, it explains the major drivers and regional dynamics of the global Prophylactic Traveler’s Diarrhea Treatment market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Bayer AG
Johnson & Johnson
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
Sanofi
GlaxoSmithKline plc
AstraZeneca
Bristol-Myers Squibb Company
Allergen Plc. Etc.
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Prophylactic Traveler’s Diarrhea Treatment Segment by Type
Antimicrobials
Antibiotics
Anti-Diarrheal
Electrolytes
Prophylactic Traveler’s Diarrhea Treatment Segment by Application
Hospitals Pharmacy
Retail Pharmacy
Drug Store
Primary Healthcare Centers
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Prophylactic Traveler’s Diarrhea Treatment market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Prophylactic Traveler’s Diarrhea Treatment market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Prophylactic Traveler’s Diarrhea Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Prophylactic Traveler’s Diarrhea Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Prophylactic Traveler’s Diarrhea Treatment revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Prophylactic Traveler’s Diarrhea Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Prophylactic Traveler’s Diarrhea Treatment revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Bayer AG, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi, GlaxoSmithKline plc, AstraZeneca and Bristol-Myers Squibb Company, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Prophylactic Traveler’s Diarrhea Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prophylactic Traveler’s Diarrhea Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prophylactic Traveler’s Diarrhea Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prophylactic Traveler’s Diarrhea Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Antimicrobials
1.2.3 Antibiotics
1.2.4 Anti-Diarrheal
1.2.5 Electrolytes
1.3 Market by Application
1.3.1 Global Prophylactic Traveler’s Diarrhea Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Drug Store
1.3.5 Primary Healthcare Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prophylactic Traveler’s Diarrhea Treatment Market Perspective (2017-2028)
2.2 Prophylactic Traveler’s Diarrhea Treatment Growth Trends by Region
2.2.1 Prophylactic Traveler’s Diarrhea Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Prophylactic Traveler’s Diarrhea Treatment Historic Market Size by Region (2017-2022)
2.2.3 Prophylactic Traveler’s Diarrhea Treatment Forecasted Market Size by Region (2023-2028)
2.3 Prophylactic Traveler’s Diarrhea Treatment Market Dynamics
2.3.1 Prophylactic Traveler’s Diarrhea Treatment Industry Trends
2.3.2 Prophylactic Traveler’s Diarrhea Treatment Market Drivers
2.3.3 Prophylactic Traveler’s Diarrhea Treatment Market Challenges
2.3.4 Prophylactic Traveler’s Diarrhea Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prophylactic Traveler’s Diarrhea Treatment Players by Revenue
3.1.1 Global Top Prophylactic Traveler’s Diarrhea Treatment Players by Revenue (2017-2022)
3.1.2 Global Prophylactic Traveler’s Diarrhea Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Prophylactic Traveler’s Diarrhea Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prophylactic Traveler’s Diarrhea Treatment Revenue
3.4 Global Prophylactic Traveler’s Diarrhea Treatment Market Concentration Ratio
3.4.1 Global Prophylactic Traveler’s Diarrhea Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prophylactic Traveler’s Diarrhea Treatment Revenue in 2021
3.5 Prophylactic Traveler’s Diarrhea Treatment Key Players Head office and Area Served
3.6 Key Players Prophylactic Traveler’s Diarrhea Treatment Product Solution and Service
3.7 Date of Enter into Prophylactic Traveler’s Diarrhea Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prophylactic Traveler’s Diarrhea Treatment Breakdown Data by Type
4.1 Global Prophylactic Traveler’s Diarrhea Treatment Historic Market Size by Type (2017-2022)
4.2 Global Prophylactic Traveler’s Diarrhea Treatment Forecasted Market Size by Type (2023-2028)
5 Prophylactic Traveler’s Diarrhea Treatment Breakdown Data by Application
5.1 Global Prophylactic Traveler’s Diarrhea Treatment Historic Market Size by Application (2017-2022)
5.2 Global Prophylactic Traveler’s Diarrhea Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Prophylactic Traveler’s Diarrhea Treatment Market Size (2017-2028)
6.2 North America Prophylactic Traveler’s Diarrhea Treatment Market Size by Type
6.2.1 North America Prophylactic Traveler’s Diarrhea Treatment Market Size by Type (2017-2022)
6.2.2 North America Prophylactic Traveler’s Diarrhea Treatment Market Size by Type (2023-2028)
6.2.3 North America Prophylactic Traveler’s Diarrhea Treatment Market Share by Type (2017-2028)
6.3 North America Prophylactic Traveler’s Diarrhea Treatment Market Size by Application
6.3.1 North America Prophylactic Traveler’s Diarrhea Treatment Market Size by Application (2017-2022)
6.3.2 North America Prophylactic Traveler’s Diarrhea Treatment Market Size by Application (2023-2028)
6.3.3 North America Prophylactic Traveler’s Diarrhea Treatment Market Share by Application (2017-2028)
6.4 North America Prophylactic Traveler’s Diarrhea Treatment Market Size by Country
6.4.1 North America Prophylactic Traveler’s Diarrhea Treatment Market Size by Country (2017-2022)
6.4.2 North America Prophylactic Traveler’s Diarrhea Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Prophylactic Traveler’s Diarrhea Treatment Market Size (2017-2028)
7.2 Europe Prophylactic Traveler’s Diarrhea Treatment Market Size by Type
7.2.1 Europe Prophylactic Traveler’s Diarrhea Treatment Market Size by Type (2017-2022)
7.2.2 Europe Prophylactic Traveler’s Diarrhea Treatment Market Size by Type (2023-2028)
7.2.3 Europe Prophylactic Traveler’s Diarrhea Treatment Market Share by Type (2017-2028)
7.3 Europe Prophylactic Traveler’s Diarrhea Treatment Market Size by Application
7.3.1 Europe Prophylactic Traveler’s Diarrhea Treatment Market Size by Application (2017-2022)
7.3.2 Europe Prophylactic Traveler’s Diarrhea Treatment Market Size by Application (2023-2028)
7.3.3 Europe Prophylactic Traveler’s Diarrhea Treatment Market Share by Application (2017-2028)
7.4 Europe Prophylactic Traveler’s Diarrhea Treatment Market Size by Country
7.4.1 Europe Prophylactic Traveler’s Diarrhea Treatment Market Size by Country (2017-2022)
7.4.2 Europe Prophylactic Traveler’s Diarrhea Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prophylactic Traveler’s Diarrhea Treatment Market Size (2017-2028)
8.2 Asia-Pacific Prophylactic Traveler’s Diarrhea Treatment Market Size by Type
8.2.1 Asia-Pacific Prophylactic Traveler’s Diarrhea Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Prophylactic Traveler’s Diarrhea Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Prophylactic Traveler’s Diarrhea Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Prophylactic Traveler’s Diarrhea Treatment Market Size by Application
8.3.1 Asia-Pacific Prophylactic Traveler’s Diarrhea Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Prophylactic Traveler’s Diarrhea Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Prophylactic Traveler’s Diarrhea Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Prophylactic Traveler’s Diarrhea Treatment Market Size by Region
8.4.1 Asia-Pacific Prophylactic Traveler’s Diarrhea Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Prophylactic Traveler’s Diarrhea Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Prophylactic Traveler’s Diarrhea Treatment Market Size (2017-2028)
9.2 Latin America Prophylactic Traveler’s Diarrhea Treatment Market Size by Type
9.2.1 Latin America Prophylactic Traveler’s Diarrhea Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Prophylactic Traveler’s Diarrhea Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Prophylactic Traveler’s Diarrhea Treatment Market Share by Type (2017-2028)
9.3 Latin America Prophylactic Traveler’s Diarrhea Treatment Market Size by Application
9.3.1 Latin America Prophylactic Traveler’s Diarrhea Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Prophylactic Traveler’s Diarrhea Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Prophylactic Traveler’s Diarrhea Treatment Market Share by Application (2017-2028)
9.4 Latin America Prophylactic Traveler’s Diarrhea Treatment Market Size by Country
9.4.1 Latin America Prophylactic Traveler’s Diarrhea Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Prophylactic Traveler’s Diarrhea Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prophylactic Traveler’s Diarrhea Treatment Market Size (2017-2028)
10.2 Middle East & Africa Prophylactic Traveler’s Diarrhea Treatment Market Size by Type
10.2.1 Middle East & Africa Prophylactic Traveler’s Diarrhea Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Prophylactic Traveler’s Diarrhea Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Prophylactic Traveler’s Diarrhea Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Prophylactic Traveler’s Diarrhea Treatment Market Size by Application
10.3.1 Middle East & Africa Prophylactic Traveler’s Diarrhea Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Prophylactic Traveler’s Diarrhea Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Prophylactic Traveler’s Diarrhea Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Prophylactic Traveler’s Diarrhea Treatment Market Size by Country
10.4.1 Middle East & Africa Prophylactic Traveler’s Diarrhea Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Prophylactic Traveler’s Diarrhea Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Prophylactic Traveler’s Diarrhea Treatment Introduction
11.1.4 Bayer AG Revenue in Prophylactic Traveler’s Diarrhea Treatment Business (2017-2022)
11.1.5 Bayer AG Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Prophylactic Traveler’s Diarrhea Treatment Introduction
11.2.4 Johnson & Johnson Revenue in Prophylactic Traveler’s Diarrhea Treatment Business (2017-2022)
11.2.5 Johnson & Johnson Recent Developments
11.3 Merck & Co., Inc.
11.3.1 Merck & Co., Inc. Company Details
11.3.2 Merck & Co., Inc. Business Overview
11.3.3 Merck & Co., Inc. Prophylactic Traveler’s Diarrhea Treatment Introduction
11.3.4 Merck & Co., Inc. Revenue in Prophylactic Traveler’s Diarrhea Treatment Business (2017-2022)
11.3.5 Merck & Co., Inc. Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Prophylactic Traveler’s Diarrhea Treatment Introduction
11.4.4 Novartis AG Revenue in Prophylactic Traveler’s Diarrhea Treatment Business (2017-2022)
11.4.5 Novartis AG Recent Developments
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Details
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Prophylactic Traveler’s Diarrhea Treatment Introduction
11.5.4 Pfizer Inc. Revenue in Prophylactic Traveler’s Diarrhea Treatment Business (2017-2022)
11.5.5 Pfizer Inc. Recent Developments
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Prophylactic Traveler’s Diarrhea Treatment Introduction
11.6.4 Sanofi Revenue in Prophylactic Traveler’s Diarrhea Treatment Business (2017-2022)
11.6.5 Sanofi Recent Developments
11.7 GlaxoSmithKline plc
11.7.1 GlaxoSmithKline plc Company Details
11.7.2 GlaxoSmithKline plc Business Overview
11.7.3 GlaxoSmithKline plc Prophylactic Traveler’s Diarrhea Treatment Introduction
11.7.4 GlaxoSmithKline plc Revenue in Prophylactic Traveler’s Diarrhea Treatment Business (2017-2022)
11.7.5 GlaxoSmithKline plc Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Prophylactic Traveler’s Diarrhea Treatment Introduction
11.8.4 AstraZeneca Revenue in Prophylactic Traveler’s Diarrhea Treatment Business (2017-2022)
11.8.5 AstraZeneca Recent Developments
11.9 Bristol-Myers Squibb Company
11.9.1 Bristol-Myers Squibb Company Company Details
11.9.2 Bristol-Myers Squibb Company Business Overview
11.9.3 Bristol-Myers Squibb Company Prophylactic Traveler’s Diarrhea Treatment Introduction
11.9.4 Bristol-Myers Squibb Company Revenue in Prophylactic Traveler’s Diarrhea Treatment Business (2017-2022)
11.9.5 Bristol-Myers Squibb Company Recent Developments
11.10 Allergen Plc. Etc.
11.10.1 Allergen Plc. Etc. Company Details
11.10.2 Allergen Plc. Etc. Business Overview
11.10.3 Allergen Plc. Etc. Prophylactic Traveler’s Diarrhea Treatment Introduction
11.10.4 Allergen Plc. Etc. Revenue in Prophylactic Traveler’s Diarrhea Treatment Business (2017-2022)
11.10.5 Allergen Plc. Etc. Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Prophylactic Traveler's Diarrhea Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Antimicrobials
Table 3. Key Players of Antibiotics
Table 4. Key Players of Anti-Diarrheal
Table 5. Key Players of Electrolytes
Table 6. Global Prophylactic Traveler's Diarrhea Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Prophylactic Traveler's Diarrhea Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Prophylactic Traveler's Diarrhea Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Prophylactic Traveler's Diarrhea Treatment Market Share by Region (2017-2022)
Table 10. Global Prophylactic Traveler's Diarrhea Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Prophylactic Traveler's Diarrhea Treatment Market Share by Region (2023-2028)
Table 12. Prophylactic Traveler's Diarrhea Treatment Market Trends
Table 13. Prophylactic Traveler's Diarrhea Treatment Market Drivers
Table 14. Prophylactic Traveler's Diarrhea Treatment Market Challenges
Table 15. Prophylactic Traveler's Diarrhea Treatment Market Restraints
Table 16. Global Prophylactic Traveler's Diarrhea Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Prophylactic Traveler's Diarrhea Treatment Revenue Share by Players (2017-2022)
Table 18. Global Top Prophylactic Traveler's Diarrhea Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prophylactic Traveler's Diarrhea Treatment as of 2021)
Table 19. Ranking of Global Top Prophylactic Traveler's Diarrhea Treatment Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Prophylactic Traveler's Diarrhea Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Prophylactic Traveler's Diarrhea Treatment Product Solution and Service
Table 23. Date of Enter into Prophylactic Traveler's Diarrhea Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Prophylactic Traveler's Diarrhea Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Prophylactic Traveler's Diarrhea Treatment Revenue Market Share by Type (2017-2022)
Table 27. Global Prophylactic Traveler's Diarrhea Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Prophylactic Traveler's Diarrhea Treatment Revenue Market Share by Type (2023-2028)
Table 29. Global Prophylactic Traveler's Diarrhea Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Prophylactic Traveler's Diarrhea Treatment Revenue Share by Application (2017-2022)
Table 31. Global Prophylactic Traveler's Diarrhea Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Prophylactic Traveler's Diarrhea Treatment Revenue Share by Application (2023-2028)
Table 33. North America Prophylactic Traveler's Diarrhea Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Prophylactic Traveler's Diarrhea Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Prophylactic Traveler's Diarrhea Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Prophylactic Traveler's Diarrhea Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Prophylactic Traveler's Diarrhea Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Prophylactic Traveler's Diarrhea Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Prophylactic Traveler's Diarrhea Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Prophylactic Traveler's Diarrhea Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Prophylactic Traveler's Diarrhea Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Prophylactic Traveler's Diarrhea Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Prophylactic Traveler's Diarrhea Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Prophylactic Traveler's Diarrhea Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Prophylactic Traveler's Diarrhea Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Prophylactic Traveler's Diarrhea Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Prophylactic Traveler's Diarrhea Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Prophylactic Traveler's Diarrhea Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Prophylactic Traveler's Diarrhea Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Prophylactic Traveler's Diarrhea Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Prophylactic Traveler's Diarrhea Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Prophylactic Traveler's Diarrhea Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Prophylactic Traveler's Diarrhea Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Prophylactic Traveler's Diarrhea Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Prophylactic Traveler's Diarrhea Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Prophylactic Traveler's Diarrhea Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Prophylactic Traveler's Diarrhea Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Prophylactic Traveler's Diarrhea Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Prophylactic Traveler's Diarrhea Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Prophylactic Traveler's Diarrhea Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Prophylactic Traveler's Diarrhea Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Prophylactic Traveler's Diarrhea Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 63. Bayer AG Company Details
Table 64. Bayer AG Business Overview
Table 65. Bayer AG Prophylactic Traveler's Diarrhea Treatment Product
Table 66. Bayer AG Revenue in Prophylactic Traveler's Diarrhea Treatment Business (2017-2022) & (US$ Million)
Table 67. Bayer AG Recent Developments
Table 68. Johnson & Johnson Company Details
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Prophylactic Traveler's Diarrhea Treatment Product
Table 71. Johnson & Johnson Revenue in Prophylactic Traveler's Diarrhea Treatment Business (2017-2022) & (US$ Million)
Table 72. Johnson & Johnson Recent Developments
Table 73. Merck & Co., Inc. Company Details
Table 74. Merck & Co., Inc. Business Overview
Table 75. Merck & Co., Inc. Prophylactic Traveler's Diarrhea Treatment Product
Table 76. Merck & Co., Inc. Revenue in Prophylactic Traveler's Diarrhea Treatment Business (2017-2022) & (US$ Million)
Table 77. Merck & Co., Inc. Recent Developments
Table 78. Novartis AG Company Details
Table 79. Novartis AG Business Overview
Table 80. Novartis AG Prophylactic Traveler's Diarrhea Treatment Product
Table 81. Novartis AG Revenue in Prophylactic Traveler's Diarrhea Treatment Business (2017-2022) & (US$ Million)
Table 82. Novartis AG Recent Developments
Table 83. Pfizer Inc. Company Details
Table 84. Pfizer Inc. Business Overview
Table 85. Pfizer Inc. Prophylactic Traveler's Diarrhea Treatment Product
Table 86. Pfizer Inc. Revenue in Prophylactic Traveler's Diarrhea Treatment Business (2017-2022) & (US$ Million)
Table 87. Pfizer Inc. Recent Developments
Table 88. Sanofi Company Details
Table 89. Sanofi Business Overview
Table 90. Sanofi Prophylactic Traveler's Diarrhea Treatment Product
Table 91. Sanofi Revenue in Prophylactic Traveler's Diarrhea Treatment Business (2017-2022) & (US$ Million)
Table 92. Sanofi Recent Developments
Table 93. GlaxoSmithKline plc Company Details
Table 94. GlaxoSmithKline plc Business Overview
Table 95. GlaxoSmithKline plc Prophylactic Traveler's Diarrhea Treatment Product
Table 96. GlaxoSmithKline plc Revenue in Prophylactic Traveler's Diarrhea Treatment Business (2017-2022) & (US$ Million)
Table 97. GlaxoSmithKline plc Recent Developments
Table 98. AstraZeneca Company Details
Table 99. AstraZeneca Business Overview
Table 100. AstraZeneca Prophylactic Traveler's Diarrhea Treatment Product
Table 101. AstraZeneca Revenue in Prophylactic Traveler's Diarrhea Treatment Business (2017-2022) & (US$ Million)
Table 102. AstraZeneca Recent Developments
Table 103. Bristol-Myers Squibb Company Company Details
Table 104. Bristol-Myers Squibb Company Business Overview
Table 105. Bristol-Myers Squibb Company Prophylactic Traveler's Diarrhea Treatment Product
Table 106. Bristol-Myers Squibb Company Revenue in Prophylactic Traveler's Diarrhea Treatment Business (2017-2022) & (US$ Million)
Table 107. Bristol-Myers Squibb Company Recent Developments
Table 108. Allergen Plc. Etc. Company Details
Table 109. Allergen Plc. Etc. Business Overview
Table 110. Allergen Plc. Etc. Prophylactic Traveler's Diarrhea Treatment Product
Table 111. Allergen Plc. Etc. Revenue in Prophylactic Traveler's Diarrhea Treatment Business (2017-2022) & (US$ Million)
Table 112. Allergen Plc. Etc. Recent Developments
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prophylactic Traveler's Diarrhea Treatment Market Share by Type: 2021 VS 2028
Figure 2. Antimicrobials Features
Figure 3. Antibiotics Features
Figure 4. Anti-Diarrheal Features
Figure 5. Electrolytes Features
Figure 6. Global Prophylactic Traveler's Diarrhea Treatment Market Share by Application: 2021 VS 2028
Figure 7. Hospitals Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Drug Store Case Studies
Figure 10. Primary Healthcare Centers Case Studies
Figure 11. Prophylactic Traveler's Diarrhea Treatment Report Years Considered
Figure 12. Global Prophylactic Traveler's Diarrhea Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Prophylactic Traveler's Diarrhea Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Prophylactic Traveler's Diarrhea Treatment Market Share by Region: 2021 VS 2028
Figure 15. Global Prophylactic Traveler's Diarrhea Treatment Market Share by Players in 2021
Figure 16. Global Top Prophylactic Traveler's Diarrhea Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prophylactic Traveler's Diarrhea Treatment as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Prophylactic Traveler's Diarrhea Treatment Revenue in 2021
Figure 18. North America Prophylactic Traveler's Diarrhea Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Prophylactic Traveler's Diarrhea Treatment Market Size Market Share by Type (2017-2028)
Figure 20. North America Prophylactic Traveler's Diarrhea Treatment Market Size Market Share by Application (2017-2028)
Figure 21. North America Prophylactic Traveler's Diarrhea Treatment Market Size Share by Country (2017-2028)
Figure 22. United States Prophylactic Traveler's Diarrhea Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Prophylactic Traveler's Diarrhea Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Prophylactic Traveler's Diarrhea Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Prophylactic Traveler's Diarrhea Treatment Market Size Market Share by Type (2017-2028)
Figure 26. Europe Prophylactic Traveler's Diarrhea Treatment Market Size Market Share by Application (2017-2028)
Figure 27. Europe Prophylactic Traveler's Diarrhea Treatment Market Size Share by Country (2017-2028)
Figure 28. Germany Prophylactic Traveler's Diarrhea Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Prophylactic Traveler's Diarrhea Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Prophylactic Traveler's Diarrhea Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Prophylactic Traveler's Diarrhea Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Prophylactic Traveler's Diarrhea Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Prophylactic Traveler's Diarrhea Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Prophylactic Traveler's Diarrhea Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Prophylactic Traveler's Diarrhea Treatment Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Prophylactic Traveler's Diarrhea Treatment Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Prophylactic Traveler's Diarrhea Treatment Market Size Share by Region (2017-2028)
Figure 38. China Prophylactic Traveler's Diarrhea Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Prophylactic Traveler's Diarrhea Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Prophylactic Traveler's Diarrhea Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Prophylactic Traveler's Diarrhea Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Prophylactic Traveler's Diarrhea Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Prophylactic Traveler's Diarrhea Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Latin America Prophylactic Traveler's Diarrhea Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Prophylactic Traveler's Diarrhea Treatment Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Prophylactic Traveler's Diarrhea Treatment Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Prophylactic Traveler's Diarrhea Treatment Market Size Share by Country (2017-2028)
Figure 48. Mexico Prophylactic Traveler's Diarrhea Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Prophylactic Traveler's Diarrhea Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Prophylactic Traveler's Diarrhea Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Prophylactic Traveler's Diarrhea Treatment Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Prophylactic Traveler's Diarrhea Treatment Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Prophylactic Traveler's Diarrhea Treatment Market Size Share by Country (2017-2028)
Figure 54. Turkey Prophylactic Traveler's Diarrhea Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Prophylactic Traveler's Diarrhea Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Prophylactic Traveler's Diarrhea Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Bayer AG Revenue Growth Rate in Prophylactic Traveler's Diarrhea Treatment Business (2017-2022)
Figure 58. Johnson & Johnson Revenue Growth Rate in Prophylactic Traveler's Diarrhea Treatment Business (2017-2022)
Figure 59. Merck & Co., Inc. Revenue Growth Rate in Prophylactic Traveler's Diarrhea Treatment Business (2017-2022)
Figure 60. Novartis AG Revenue Growth Rate in Prophylactic Traveler's Diarrhea Treatment Business (2017-2022)
Figure 61. Pfizer Inc. Revenue Growth Rate in Prophylactic Traveler's Diarrhea Treatment Business (2017-2022)
Figure 62. Sanofi Revenue Growth Rate in Prophylactic Traveler's Diarrhea Treatment Business (2017-2022)
Figure 63. GlaxoSmithKline plc Revenue Growth Rate in Prophylactic Traveler's Diarrhea Treatment Business (2017-2022)
Figure 64. AstraZeneca Revenue Growth Rate in Prophylactic Traveler's Diarrhea Treatment Business (2017-2022)
Figure 65. Bristol-Myers Squibb Company Revenue Growth Rate in Prophylactic Traveler's Diarrhea Treatment Business (2017-2022)
Figure 66. Allergen Plc. Etc. Revenue Growth Rate in Prophylactic Traveler's Diarrhea Treatment Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed